Field-deployable viral diagnostics using CRISPR-Cas13
Posted by btwatson on April 27, 2018 12:03 am
Tags:
Categories:
Crispr Articles
Source: Field-deployable viral diagnostics using CRISPR-Cas13
Cameron Myhrvold
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Catherine A. Freije
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
Jonathan S. Gootenberg
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.McGovern Institute for Brain Research, MIT, Cambridge, MA 02139, USA.Department of Brain and Cognitive Science, MIT, Cambridge, MA 02139, USA.Department of Biological Engineering, MIT, Cambridge, MA 02139, USA.
Omar O. Abudayyeh
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.McGovern Institute for Brain Research, MIT, Cambridge, MA 02139, USA.Department of Brain and Cognitive Science, MIT, Cambridge, MA 02139, USA.Department of Biological Engineering, MIT, Cambridge, MA 02139, USA.Department of Health Sciences and Technology, MIT, Cambridge, MA 02139, USA.
Hayden C. Metsky
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Department of Electrical Engineering and Computer Science, MIT, Cambridge, MA 02139, USA.
Ann F. Durbin
Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.Institute for Medical Engineering and Science, MIT, Cambridge, MA 02139, USA.
Max J. Kellner
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.
Amanda L. Tan
Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
Lauren M. Paul
Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
Leda A. Parham
Centro de Investigaciones Genética, Instituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Kimberly F. Garcia
Centro de Investigaciones Genética, Instituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Kayla G. Barnes
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, MA 02115, USA.
Bridget Chak
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Adriano Mondini
Araraquara Laboratory of Public Health, School of Pharmaceutical Sciences, São Paulo State University, São Paulo, Brazil.
Mauricio L. Nogueira
Laboratorio de Pesquisas em Virologia, Faculdade de Medicina de Sao Jose do Rio Preto, São Paulo, Brazil.
Sharon Isern
Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
Scott F. Michael
Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
Ivette Lorenzana
Centro de Investigaciones Genética, Instituto de Investigacion en Microbiologia, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Nathan L. Yozwiak
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.
Bronwyn L. MacInnis
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, MA 02115, USA.
Irene Bosch
Institute for Medical Engineering and Science, MIT, Cambridge, MA 02139, USA.Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
Lee Gehrke
Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.Institute for Medical Engineering and Science, MIT, Cambridge, MA 02139, USA.Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA.
Feng Zhang
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.McGovern Institute for Brain Research, MIT, Cambridge, MA 02139, USA.Department of Brain and Cognitive Science, MIT, Cambridge, MA 02139, USA.Department of Biological Engineering, MIT, Cambridge, MA 02139, USA.
Pardis C. Sabeti
Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA 02142, USA.Center for Systems Biology, Department of Organismal and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.Ph.D. Program in Virology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.Department of Immunology and Infectious Disease, Harvard School of Public Health, Boston, MA 02115, USA.Howard Hughes Medical Institute (HHMI), Chevy Chase, MD 20815, USA.
Published at Thu, 26 Apr 2018 17:50:39 +0000
Crispr News
-
Intellia Therapeutics: A Leader in CRISPR/Cas9 Genome Editing ... - Best StocksApril 2, 2023
-
CRISPR Therapeutics AG (NASDAQ:CRSP) CEO Samarth Kulkarni ... - MarketBeatApril 1, 2023
-
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics - The Motley FoolApril 1, 2023
-
Pediatric Cancer Cell Atlas Uncovers Clues About Cancer Drivers ... - GenomeWebMarch 31, 2023
-
Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce ... - Cancer DiscoveryMarch 31, 2023
-
Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days - Yahoo FinanceMarch 31, 2023
-
This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market ... - NasdaqMarch 31, 2023
-
Genome-wide tiled detection of circulating Mycobacterium ... - Nature.comMarch 31, 2023
-
5 Bargain-Basement Stocks to Buy Right Now - NasdaqMarch 31, 2023
-
Buy Crispr Therapeutics On Approval Odds (NASDAQ:CRSP) - Seeking AlphaMarch 31, 2023
-
Opportunity in the CRISPR Gene Editing Market | High Market ... - MedgadgetMarch 31, 2023
-
CRISPR cats and dogs? Royal Society for the Prevention of Cruelty ... - Genetic Literacy ProjectMarch 31, 2023
-
CRISPR pioneer Jennifer Doudna to speak April 4 in Chicago - Northwestern NowMarch 31, 2023
-
Brassinosteroid gene regulatory networks at cellular resolution in ... - ScienceMarch 30, 2023
-
CRISPR editing in the lung with novel lipids - Nature.comMarch 30, 2023
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.